0604 pub planning

SPECIAL ISSUE
July/August 2010
THE FORUM FORTHE INDUSTRY EXECUTIVE
100
of the Most
Inspiring People
P U B L I C AT I O N
www.pharmavoice.com
Letter from the EDITOR
THE FORUM FOR THE INDUSTRY EXECUTIVE
The PharmaVOICE 100: 2010
Volume 10 • Number 7
PUBLISHER
EDITOR
CREATIVE DIRECTOR
Lisa Banket
Taren Grom
Marah Walsh
MANAGING EDITOR
Denise Myshko
SENIOR EDITOR
Robin Robinson
FEATURES EDITOR
Kim Ribbink
CONTRIBUTING EDITOR
Carolyn Gretton
DESIGN ASSOCIATE
Ariel Medel
NATIONAL ACCOUNT MANAGER
Cathy Tracy
CIRCULATION ASSISTANT
Kathy Deiuliis
Copyright 2010
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Ten, Number Seven
PharmaVOICE (ISSN: 1932961X) is published monthly
except joint issues in July/Aug. and Nov./Dec., by
PharmaLinx LLC, P.O. Box 327, Titusville, NJ 08560.
Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.
Postmaster: Send address changes to PharmaVOICE,
P.O. Box 292345, Kettering, OH 45429-0345.
PharmaVOICE Coverage and Distribution:
Domestic subscriptions are available at $190 for one
year (10 issues). Foreign subscriptions: 10 issues
US$360. Contact PharmaVOICE at P.O. Box 327,
Titusville, NJ 08560. Call us at 609.730.0196 or FAX your
order to 609.730.0197.
Contributions: PharmaVOICE is not responsible for
unsolicited contributions of any type. Unless otherwise
agreed in writing, PharmaVOICE retains all rights on
material published in PharmaVOICE for a period of six
months after publication and reprint rights after that
period expires. E-mail: tgrom@pharmavoice.com.
Change of address: Please allow six weeks for a change
of address. Send your new address along with your subscription label to PharmaVOICE, P.O. Box 292345, Kettering,
OH 45429-0345. Call us at 800.607.4410 or FAX your change
to 937.890.0221. E-mail: mwalsh@pharmavoice.com.
IMPORTANT NOTICE: The post office will not forward
copies of this magazine. PharmaVOICE is not responsible for replacing undelivered copies due to lack of or
late notification of address change.
Advertising in PharmaVOICE: To advertise in PharmaVOICE please contact our Advertising Department at
P.O. Box 327, Titusville, NJ 08560, or telephone us at
609.730.0196. E-mail: lbanket@pharmavoice.com.
Letters
Send your letters to feedback@pharmavoice.com.
Please include your name, title, company, and business phone number. Letters chosen for publication
may be edited for length and clarity. All submissions
become the property of PharmaLinx LLC.
Printed on
recycled paper
Every year, I think this is it, we’ve reached
the pinnacle. And yet, every year, I
continue to be amazed by the
individuals whom our readers have
identified as the most inspiring,
motivating, and outstanding leaders
in the life-sciences industry.
This special issue, now in its sixth
year, has become a must-read and one
of the most-anticipated publications of
the year. It is our extreme pleasure to
once again be able to pay tribute to the
men and women who are driving change,
providing guidance, and fostering relationships
to position the industry in the best way possible to
serve the ultimate stakeholders: patients.
The individuals featured in this issue are as diverse in their talents, skills, and know-how as
their roots.They come from around the United States and around the world — Argentina,
Australia, Canada, China, Cuba, England, France, India, Ireland, Italy, Malaysia, Nigeria, and
Zimbabwe — to name just a few of their countries of origin.This broad geographic
representation is a testament to not only how global the life-sciences industry has become, but
how easy it is to transcend national borders through positive actions that influence others in a
meaningful and substantive way.We are equally delighted that PharmaVOICE’s reach allows us
to bring you their stories.
This special publication, which has become known as the feel-good issue of the year, is
packed with in-depth profiles showcasing the industry’s best and brightest.To make the issue
easier to navigate, we have divided the honorees into categories that we think best capture
their expertise. Please note, however, that most of this year’s honorees could easily fit into
several of the following sections: commanders and chiefs, entrepreneurs, change agents, clinical
specialists, researchers and scientists, marketers, creatives, mentors, and technologists.
In spite of shifting market landscapes, uncertain business conditions, and reduced headcounts, these industry leaders are overcoming myriad obstacles as they set the gold standard
for corporate leadership, cutting-edge research and development, forward-thinking technology
solutions, out-of-the-box creative executions and marketing strategies, and outstanding career
development training processes.
Not only are the honorees contributing to the growth of their organizations, they are
community leaders and serve as members of industry-related associations and donate time to
worthy charities and philanthropic organizations.
Each year the selection process becomes more difficult.With thousands of nominations to
consider, our editorial team relies on the personal stories and accounts that describe why these
individuals are special.We want to thank all of our readers who took time out of their busy
schedules to nominate those who have made, and continue to make, a difference in their
careers, lives, and organizations.The quality and number of nominations received this year
reaffirms that the industry is driven by people of vision and passion who are dedicated to
improving healthcare and patients’ lives.
We also want to thank all of our PharmaVOICE 100 honorees for taking time to share their
personal stories with us.These insights provided our team with a wealth of information on
which to base this year’s profiles.
Please join us in extending warm congratulations to this august group as we celebrate the
well-deserving individuals featured in this sixth annual PharmaVOICE 100 issue. I hope you
enjoy getting to know this distinguished group as much as we did. And don’t forget to check
out the exclusive bonus text found only in our digital edition, which can be accessed at
pharmavoice.com, to read more of their stories.
We can’t wait to see who makes next year’s list. Submit your nominations for 2011 now!
The Change AGENTS
DR. LEO FRANCIS
ENERGY AND
IDEAS IGNITED
IT WAS APPARENT FROM THE START OF HIS
CAREER THAT LEO FRANCIS, PH.D.,WAS A
LEADER IN THE MAKING. FROM HIS EARLY
DAYS IN THE INDUSTRY, DR. FRANCIS’
PROFESSIONALISM AND INEXORABLE DRIVE
FOR EXCELLENCE IN ALL ASPECTS OF HIS
WORK HAVE SHONE THROUGH.
His achievements have led to extraordinary
progressions up the corporate ladder in different fields within the industry and in each position of increasing responsibility he has won the
praise of his peers and reports through consistent displays of business success and effective
leadership.
Clients and co-workers alike love working
with Dr. Francis because of his positive outlook and contagious laugh, his vision, and his
ability to motivate through persuasion not
intimidation.
What makes Dr. Francis stand out is his
willingness to make unorthodox decisions. For
example, when preparing to make a critical presentation to a potential client while at a former
employer, he surmised that his team wouldn’t
be ready on the scheduled date. Rather than
leave the date in place and hope for the best, he
went in person to the client and asked for a postponement. The team made the presentation at a
later date and the company got the account.
His position as president of the Publicis
Medical Education Group (PMEG) provides a
global pulpit and access to key leaders who are
infected and affected by his energy and ideas.
Always on the lookout for the next frontier of
medical education, his prescience and foresight
have supported a surge in the use of digital
technology as a key resource in globalizing
medical education and advancing healthcare.
He set the goal to make PMEG a group of
next-generation medical education companies
that use digital technology tools for collaboration, information exchange, and knowledge
transfer to optimally deliver value-added services that empower healthcare professionals
and patients with knowledge, information,
and awareness, ultimately creating a higher
level of healthcare service and performance.
A strong proponent of the patient’s role in
Dr. Leo Francis, President of Publicis Medical Education,
is evangelistic in his enthusiasm and passion for
developing team members to become leaders in the
field.
DID YOU KNOW?
Charismatic.Visionary.
NAME: Leo P. Francis, Ph.D.
CURRENT POSITION: President, Publicis
Medical Education Group
EDUCATION: Ph.D., University of Central
In 2009, Dr. Leo Francis scored two of
the three winning goals for his soccer
team in the MCSSA state summer
league championship final.
Lancashire; B.Sc., Bristol Polytechnic
?
PLACE OF BIRTH: Birmingham, U.K.
FIRST JOB: Newspaper delivery boy
FIRST INDUSTRY-RELATED JOB: Clinical
research associate, Gensia Europe Ltd.
DREAM JOB: Philanthropist
healthcare, Dr. Francis is a vocal and effective
advocate for education to improve outcomes
and create value. His vision for the world of
medical education and his ability to articulate
its importance to the health and wellness dialogue are inspiring.
For Dr. Francis, it’s all about inspiring his
leadership team to be better managers not only
to ensure the success of the staff members they
lead but to truly make a difference in healthcare. He inspires his colleagues to think about
the current climate as an opportunity to
improve the status quo, and his actions support his philosophy.
Dr. Francis has created focused brand development and messaging campaigns across several therapeutic areas, including cardiovascular, neurology, psychiatry, and anti-infectives.
He has also published extensively in peerreviewed scientific journals.
PharmaVOICE
PROFESSIONAL MENTOR: Dr. Dennis N.
Joseph, former boss
PROFESSIONAL ASSOCIATION: Healthcare
Businesswomen’s Association
CONNECTED VIA: LinkedIn, Plaxo, Naymz,
Facebook
WORDS TO LIVE BY: Looking good, feeling
good; and do what you say
July/August 2010
3
The Change AGENTS
DR. LEO FRANCIS • IMAGINING THE POSSIBLE
Getting Personal with DR. LEO FRANCIS
FAMILY: Wife, Lyn; Son, Isaac
INSPIRATION: His family, Martin Luther King,
READING LIST: The American Constitution; Money Ball by
Gandhi, Nelson Mandela
Michael Lewis;The Winning Edge by George Alston;
AutoWeek; Business: 1001 Ways to Reward Employees by
Bob Nelson;The Power of Learning by Klas Mellander
TOP IPOD DOWNLOADS: R&B and Jazz, Ashanti, Kenny
HOBBIES: Martial arts, soccer, fitness training, performance
sports cars, dining out, collecting watches
GIVING BACK: Community volunteer for U.K.-based mentor
Lattimore,Will Downing
LIFE LESSONS: Be true to and believe in yourself
A LITTLE KNOWN FACT: Until the age of 20, he played
high-level competitive cricket
project
UNDER THE CLOAK OF INVISIBILITY: Visit No. 10 Downing St.
BUCKET LIST: Own a Lamborghini; live to at least 100
and The White House
With equal command of science and business, Leo Francis, Ph.D., is able to provide
exemplary leadership to his employees, colleagues, and friends.
A driven and energized leader, Dr. Francis
believes everything is possible and will not
stop until the goal is achieved. His enthusiasm
ignites all those around him, co-workers and
clients alike, and he encourages people to go
the extra mile.
A forward-thinking leader, Dr. Francis
never settles for the standard or the norm, but
constantly pushes himself and others to think
bigger, go farther, and try something new.
Since joining Publicis Medical Education
Group in January 2008, he has quickly and
adeptly assumed the role of go-to counselor for
clients and staff. In two short years as president, Dr. Francis has driven strong organiza-
tion growth, significantly improved staff
retention rates, diversified the company’s
client base, instilled a nurturing culture of
excellence, and brought about transformational perspectives from digital to metrics in communications.
A skilled team builder, he recently set up a
cross-functional meeting to engage people to
discuss what they believe are the future trends;
he believes vision is developed and owned by
everyone. He also has a great ability to remain
calm under pressure, and he is always clear and
concise about his vision and expectations.
With an extraordinary ability to create
meaningful and caring relationships with all
he encounters, Dr. Francis will go out of his
way to help others, listen to other points of
view, and be open to new ideas.
While he expects the best from his staff, he
4
PharmaVOICE
July/August 2010
does so in a way that is
and
non-threatening
empowering. Titles are
not important to Dr.
Francis, who treats everyone with the same
respect, and is present
and engaged with everyone with whom he interacts. Dr. Francis cares
deeply about how
employees are engaged, motivated, and
involved in their roles, and continuously provides direct and honest feedback to everyone.
When there is a win, no matter how big or
how small, Dr. Francis is one of the first to
send his note of gratitude and appreciation for
the accomplishment.
Dr. Francis believes that when others excel,
he excels, and that the collective commitment
and sharing of knowledge create positive outcomes in work and in life. He is a strong supporter of the HBA, and members of his leadership team are active and senior participants
in the organization — from regional chapter
groups to HBA board memberships.
While excelling in the workplace, Dr.
Francis understands the importance of balancing work with personal life. Time outside of
the office is devoted to his wife Lyn, family,
and Dr. Francis is deeply in helping his son
with schoolwork and on the soccer field. ✦
The PharmaVOICE 100
WHO’S ON THE LIST — 2010
Anavex Life Sciences . . . . . . . . . . .Cameron Durrant, M.D.
ApotheCom . . . . . . . . . . . . . . . . . . . . .David Dunn
Astellas Pharma US . . . . . . . . . . . . .Margaret Long
AstraZeneca . . . . . . . . . . . . . . . . . . . .David Brennan
bioCapture . . . . . . . . . . . . . . . . . . . . . .Johanna Allston, Ph.D.
C3i . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Robert Piwko
Cegedim Dendrite . . . . . . . . . . . . . .Angela Miccoli
Cipla Ltd. . . . . . . . . . . . . . . . . . . . . . . . .Yusuf Hamied, Ph.D.
ClearTrial . . . . . . . . . . . . . . . . . . . . . . . .Mike Soenen
closerlook . . . . . . . . . . . . . . . . . . . . . .David Ormesher
Cognizant . . . . . . . . . . . . . . . . . . . . . .Nagarajan Srivatsan
Complete Genomics . . . . . . . . . . . .Clifford Reid, Ph.D.
Daiichi Sankyo . . . . . . . . . . . . . . . . . .Joe Pieroni
Delta Pharma . . . . . . . . . . . . . . . . . . .Christina Fleming, Ph.D.
Derycz Scientific . . . . . . . . . . . . . . . .Peter Derycz
Diagnostics for All . . . . . . . . . . . . . . .Una Ryan, Ph.D.
DWA Healthcare
Communications Group . . . . . .Deborah Wood
Echo Torre Lazur . . . . . . . . . . . . . . . .Bill McEllen
eClinical Solutions . . . . . . . . . . . . . .Susan Bornstein
EMD Serono . . . . . . . . . . . . . . . . . . . .James Hoyes
Epocrates . . . . . . . . . . . . . . . . . . . . . . .Rose Crane
eResearch Technology . . . . . . . . . .Joel Morganroth, M.D.
Excel Life Sciences . . . . . . . . . . . . . .Vijai Kumar, M.D.
Fate Therapeutics . . . . . . . . . . . . . . .Sheng Ding, Ph.D.
FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Michael Marcarelli, Pharm.D.
Firecrest Clinical . . . . . . . . . . . . . . . .Brendan Buckley, M.D., D.Phil.
Genentech . . . . . . . . . . . . . . . . . . . . .Carol Wells
GeoVax . . . . . . . . . . . . . . . . . . . . . . . . .Robert McNally, Ph.D.
Group DCA . . . . . . . . . . . . . . . . . . . . . .Rob Likoff
GSW . . . . . . . . . . . . . . . . . . . . . . . . . . . .Bruce Rooke
Halloran Consulting Group . . . . . .Laurie Halloran
Harrison & Star . . . . . . . . . . . . . . . . . .Larry Star
Healthy Advice Networks . . . . . . .Tom Campbell
Horizon Pharma . . . . . . . . . . . . . . . . .Tim Walbert
HRA Pharma . . . . . . . . . . . . . . . . . . . .Erin Gainer, Ph.D.
Humedica . . . . . . . . . . . . . . . . . . . . . .Michael Weintraub
i3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Glenn Bilawsky
iGuard.org, a Quintiles Co. . . . . . . .Hugo Stephenson, M.D.
INC Research . . . . . . . . . . . . . . . . . . . .Silvia Zieher, M.D.
Intouch Solutions . . . . . . . . . . . . . . .Wendy Blackburn
ISTA Pharmaceuticals . . . . . . . . . . .Vicente Anido Jr., Ph.D.
Johnson & Johnson . . . . . . . . . . . . .Alex Gorsky
Johnson & Johnson . . . . . . . . . . . . .Kevin Scott
Kantar Health . . . . . . . . . . . . . . . . . . .Lynnette Cooke
Kendle . . . . . . . . . . . . . . . . . . . . . . . . . .Candace Kendle, Pharm.D.
Leslie Gaber Associates . . . . . . . . .Leslie Gaber
Lux Capital Management . . . . . . .Robert Paull
MannKind . . . . . . . . . . . . . . . . . . . . . . .Alfred Mann
The Medical Affairs
Company . . . . . . . . . . . . . . . . . . . . .Jennifer King
MediciGlobal . . . . . . . . . . . . . . . . . . . .Nick Halkitis
Medicus Life Brands . . . . . . . . . . . . .Lisa Ebert
Medidata Solutions
Worldwide . . . . . . . . . . . . . . . . . . .Graham Bunn, Ph.D.
Indexed by Company Affiliation
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . .Jeff Berkowitz
Merck . . . . . . . . . . . . . . . . . . . . . . . . . .Richard Branton
MicroMass
Communications . . . . . . . . . . . . .Jamie Cobb
Millennium:The Takeda
Oncology Co. . . . . . . . . . . . . . . . . .Deborah Dunsire, M.D.
Nigerian NAFDAC . . . . . . . . . . . . . . .Paul Orhii, M.D., Ph.D.
Novartis . . . . . . . . . . . . . . . . . . . . . . . .David Epstein
Novartis . . . . . . . . . . . . . . . . . . . . . . . . .Joe Jimenez
Novartis . . . . . . . . . . . . . . . . . . . . . . . .Ted White
Oceana Therapeutics . . . . . . . . . . .John Spitznagel
Octagon Research Solutions . . . .James Walker
Ogilvy CommonHealth . . . . . . . . .Scott Watson
Omnicare Clinical Research . . . . .James Pusey, M.D.
On-Q-ity . . . . . . . . . . . . . . . . . . . . . . . .Mara Aspinall
Outcome . . . . . . . . . . . . . . . . . . . . . . . .Richard Gliklich, M.D.
Palio . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dan Bobear
Pfizer (formerly) . . . . . . . . . . . . . . . . .Mohan Bangalore, Ph.D.
Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . .Craig Lipset
Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . . .Paulash Mohsen
Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . .Joe Shields
PharmaNet . . . . . . . . . . . . . . . . . . . . .Jeff Trotter
PHT Corp. . . . . . . . . . . . . . . . . . . . . . . .Barbara Marino, Ph.D.
Physicians Interactive . . . . . . . . . . .Devin Paullin
Pink Tank . . . . . . . . . . . . . . . . . . . . . . . .Marcee Nelson
PPD . . . . . . . . . . . . . . . . . . . . . . . . . . . .Randy Anderson, Ph.D.
Publicis Healthcare
Communications Group . . . . . .Nick Colucci
Publicis Medical Education . . . . . .Leo Francis, Ph.D.
Publicis Touchpoint
Solutions . . . . . . . . . . . . . . . . . . . . .Rick Keefer
Purohit Navigation . . . . . . . . . . . . . .Ahnal Purohit, Ph.D.
Qforma . . . . . . . . . . . . . . . . . . . . . . . . .Alan Reicheg
QPharma . . . . . . . . . . . . . . . . . . . . . . .Jeff Boatman
Quotient Bioresearch . . . . . . . . . . .Peter Scholes, Ph.D.
Regan Campbell Ward
Group . . . . . . . . . . . . . . . . . . . . . . . .Dan Hassan
Roche . . . . . . . . . . . . . . . . . . . . . . . . . . .Maryann Szabo
Roska Healthcare . . . . . . . . . . . . . . .Jay Bolling
Sanofi-Aventis . . . . . . . . . . . . . . . . . . .Michael Agard
Sanofi-Aventis . . . . . . . . . . . . . . . . . . .Chris Viehbacher
Shire Human
Genetic Therapies . . . . . . . . . . . .William Ciambrone
Snow Companies . . . . . . . . . . . . . . .Brenda Snow
Torre Lazur McCann . . . . . . . . . . . .Joanne Duckman
UBC . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Chad Clark
Unigene Laboratories . . . . . . . . . . .Warren Levy, Ph.D.
Veeva Systems . . . . . . . . . . . . . . . . . .Peter Gassner
Venn Life Sciences . . . . . . . . . . . . . .Marlene Llopiz-Aviles, M.D.
Verilogue . . . . . . . . . . . . . . . . . . . . . . .Jeff Kozloff
Vertex Pharmaceuticals . . . . . . . . .Craig Sorensen, Ph.D.
Wishbone . . . . . . . . . . . . . . . . . . . . . .Steve Hamburg
Wolfe Laboratories . . . . . . . . . . . . . .Janet Wolfe, Ph.D.
Y Brand . . . . . . . . . . . . . . . . . . . . . . . . .Vince Parry
PharmaVOICE
David Brennan
AstraZeneca
Angela Miccoli
Cegedim Dendrite
Bill McEllen
Echo Torre Lazur
James Hoyes
EMD Serono
Rob Likoff
Group DCA
Jennifer King
The Medical Affairs
Company
Dr. Graham
Bunn
Medidata
Jamie Cobb
MicroMass
Communications
Dr. Ahnal Purohit
Purohit Navigation
Joanne Duckman
Torre Lazur McCann
July/August 2010
5